The science behind peptide therapy is still emerging, and some applications are currently based on early-stage clinical research
Control groups of mice were maintained on LD or WD and given sham (10 mL/kg body weight sterile saline) injections throughout the study (termed LD/LD-V, or LD control, and WD/WD-V, or WD control, groups
This method bypasses the digestive system, making it ideal for people who: Have trouble absorbing B12 due to gastrointestinal issues (like Crohns disease or coeliac disease) Are on medications that interfere with B12 absorption (like metformin or anti-acids) Follow vegan or vegetarian diets Have undergone gastric surgery
This active B12 is readily absorbed, aiding in the maintenance of healthy nerve cells, supporting red blood cell formation, and contributing to overall neurological function in the body.*
Most users report noticeable improvements within 7 to 14 days when using injectable BPC-157 at doses between 0.25mg and 0.5mg daily
Targeting NNMT as an upstream metabolic regulator